Commercial opportunities for emerging infectious diseases vaccine developers
Although development of interventions for emerging infectious diseases (EIDs) has traditionally been limited by a lack of market incentives, novel funding mechanisms and global partnerships for outbreak preparedness are expanding the commercial prospects for vaccine developers, according to analytics company GlobalData
Breaking News
Boehringer Ingelheim opens Respimat plant in Catalonia
Facility in Sant Cugat, 30-minute northwest of Barcelona, will produce 25 million units per year; more than half the ...
Boehringer announces multimillion-dollar investment to expand oral solid dosage production in Mexico
Cash injection to increase exports of anti-diabetic drugs to the US, Argentina, Colombia and Brazil
Nelipak and Optel join forces on seal inspection technology
Alliance aims to commercialise a solution to verify quality of a thermoformed seal in real time while detecting ...
Pharmapack Europe review: Sizeable growth potential in 2019
Patient-centricity, eco-friendly and smart packaging trends mark the biggest growth drivers and innovations in 2019
Recipharm introduces end-to-end inhalation platform
Platform offers service from early stage development through commercial manufacturing
Nemera: RetroNose enhances therapeutic efficacy of nasal treatments
Drug delivery maker will present further findings of research at RDD 2019 Conference at the Estoril Congress Center in ...
Supporting precision with precision
As biologics steadily grow in pipeline development and commercialisation, they inherently require precise and ...
Russian syringe maker is looking for manufacturing site in Belarus
Ural Medical Company and other manufacturers are looking to make connections between the countries
Encube Ethicals opens new topical manufacturing facility
The 350 sqm facility in Goa caters for topical products, including those containing HPAPIs
Bacteria as ingredients in skincare products: a manufacturing challenge
The concept of friendly bacteria is now well embedded in the public’s imagination, and various food and drinks ...
A new paradigm in vaccines and cancer treatments
Specialist pharmaceutical company N4 Pharma is developing Nuvec, a unique non-viral adjuvant delivery system for ...
Platform solutions for biotech pharmaceuticals
Today’s innovative pharmaceuticals and new approaches to cell or gene therapies offer new treatment solutions for ...
Vetter’s Skokie facility expansion nears completion
The expansion features storage space increase of 3,100 sqft, including a freezer farm as well as a planned walk-in ...
Enesi and Oxford Vaccine Group partner to immunise against plague
Collaboration aims to create an easy-to-use solid dose plague vaccine for use in areas of outbreak and as a defence ...
In Brief
Most Popular in Drug Delivery
Suppliers in drug delivery
Reports
